BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BudMaps - ECPv6.0.13.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://budmaps.com.br/es
X-WR-CALDESC:Eventos para BudMaps
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Sao_Paulo
BEGIN:STANDARD
TZOFFSETFROM:-0200
TZOFFSETTO:-0300
TZNAME:-03
DTSTART:20180218T020000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0300
TZOFFSETTO:-0200
TZNAME:-02
DTSTART:20181104T030000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20180127T132000
DTEND;TZID=America/Sao_Paulo:20180127T172000
DTSTAMP:20260430T060227
CREATED:20180117T235242Z
LAST-MODIFIED:20180117T235242Z
UID:99994988-1517059200-1517073600@budmaps.com.br
SUMMARY:2ª reunião - Marcha da Maconha Rio de Janeiro
DESCRIPTION:Nossa primeira reunião aconteceu no último dia 13\, quando já decidimos alguns pontos da Marcha desse ano: \n– DATA: 05/05\n– TRAJETO: Jardim de Alah – Arpoador\n– Concentração às 14h20\, saída às 16h20\n– TEMA: Foram levantados\, principalmente\, as questões relativas a conjuntura nacional (CONAD\, Osmar Terra\, Temer\, Câmara e Senado\, julgamento no STF\, dentre outros). Ficamos de aprofundar mais isso na próxima reunião antes de definir o tema.\n– MOBILIZAÇÃO: Ficou também para ser debatido numa próxima reunião nossas estratégias de divulgação e mobilização para a Marcha. É importante pensarmos alguma coisa ainda pro carnaval.\n____________________________________________________ \nÉ sempre bom lembrar que as reuniões são abertas a qualquer pessoa favorável a uma mudança na política de drogas hoje vigente em nosso país\, no sentido de acabar com a proibição. Todos os presentes tem direito igual a voz e voto. Esperamos todos lá! \nNossa vitória não será por acidente!\nLegaliza! \nObs: A reunião não termina necessariamente às 18h. O facebook nos exige estipular o horário de término de um evento\, mas a reunião só termina quando os presentes assim o decidirem\, o que pode ser antes ou depois das 18h.
URL:https://budmaps.com.br/es/evento/2a-reuniao-marcha-da-maconha-rio-de-janeiro/
ATTACH;FMTTYPE=image/jpeg:https://budmaps.com.br/wp-content/uploads/facebook_event_145212112855191.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Sao_Paulo:20180128T000000
DTEND;TZID=America/Sao_Paulo:20180128T045900
DTSTAMP:20260430T060227
CREATED:20180105T225257Z
LAST-MODIFIED:20180105T225257Z
UID:99994972-1517097600-1517115540@budmaps.com.br
SUMMARY:Exploring Psychedelic Medicine - Fort Collins
DESCRIPTION:You are invited a launch party and benefit for MDMA-assisted psychotherapy research in Fort Collins\, Colorado\, on Saturday\, January 27\, 2018.  \nCelebrate the launch of our new research site at the Wholeness Center in Fort Collins\, where MDMA-assisted psychotherapy will be investigated as a treatment for posttraumatic stress disorder (PTSD) in a Phase 3 clinical trial. \nReserve your tickets today to network with like-minded people\, meet movers and shakers in the psychedelic research community\, enjoy light refreshments\, and contribute to this vital and promising movement. \nPurchase tickets: maps.org/fortcollins2018 \nMAPS Founder and Executive Director\, Rick Doblin\, Ph.D.\, will hold an illuminating conversation about how the path to legalizing psychedelic medicine leads to his vision of a post-prohibition world; where psychedelics are used as prescription medicines\, as valuable tools for inspiring creativity\, for personal and spiritual growth\, and for catalyzing resolutions to global and social conflicts. \nLeading researchers will join in the discussion to highlight the progress of MAPS-sponsored clinical trials investigating MDMA-assisted psychotherapy as a treatment for posttraumatic stress disorder (PTSD).  \n— \nBreakthrough Therapy Designation: \nPreliminary studies have shown that MDMA combined with psychotherapy can help people overcome PTSD. After careful review of these studies\, the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to MDMA for the treatment of PTSD. By granting Breakthrough Therapy Designation\, the FDA has agreed that this treatment may have a meaningful advantage and greater compliance over available medications for PTSD. Breakthrough Therapy Designation also means that the FDA will work closely with MAPS to complete Phase 3 trials\, the final phase of research\, as efficiently as possible. \nPhase 3 trials require more clinical sites\, more therapists\, more patients\, and more support. This research is crucial to receiving government approval of MDMA-assisted psychotherapy as a legal treatment\, which would radically shift policy and public perception surrounding psychedelics. \n— \nHealing Trauma: \nThere is a need unmet by modern psychiatry that psychedelic-assisted therapies can fill. By supporting groundbreaking research with psychedelic therapies\, we can work together toward healing millions of people suffering from PTSD. \nWe can create this future together. Join us in opening the doors to new models for healing and personal growth. Proceeds from the event benefit MAPS’ research and education programs. \n— \nSpeakers: \nMAPS Founder and Executive Director Rick Doblin\, Ph.D.\, has a professional goal to help develop legal contexts for the beneficial uses of psychedelics and marijuana\, primarily as prescription medicines but also for personal growth for otherwise healthy people\, and eventually to become a legally licensed psychedelic therapist. \nDr. Scott Shannon\, a holistic physician\, psychiatrist\, acupuncturist\, and teacher\, will serve as the Principal Investigator Fort Collins PI at his clinic\, Wholeness Center\, which provides cross-disciplinary evaluation and care for mental health concerns. In 2001\, Dr. Shannon published the first textbook on holistic psychiatry and continues to be published widely. He shares his knowledge as an Assistant Clinical Professor at the University of Colorado and through Psychiatry MasterClass\, a program he was central in creating that provides professionals with in-depth education in integrative mental health. \nHania Withem was a participant in MAPS’ Phase 2 clinical trial of MDMA-assisted psychotherapy for posttraumatic stress disorder. Hania currently lives and works in Fort Collins\, Colorado. \nPurchase tickets: maps.org/fortcollins2018���\n— \nQuestions? Contact events@maps.org \nSpecial thanks to our host committee (in formation): Jade Netanya Ullmann. \n— \nAbout MAPS: \nThe Multidisciplinary Association for Psychedelic Studies (MAPS) is a non-profit research and educational organization that develops medical\, legal\, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. Founded in 1986\, MAPS’ highest priority is to develop MDMA-assisted psychotherapy into an FDA-approved prescription treatment for PTSD. \n�Learn about our research and other events at maps.org
URL:https://budmaps.com.br/es/evento/exploring-psychedelic-medicine-fort-collins/
ATTACH;FMTTYPE=image/jpeg:https://budmaps.com.br/wp-content/uploads/facebook_event_1865183693722268.jpg
END:VEVENT
END:VCALENDAR